#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	16184	16S	1529	1529	100.0	16S.l15.c30.ctg.1	2342	836.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1575	1575	C	1033	C,T	1032,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	16184	16S	1529	1529	100.0	16S.l15.c30.ctg.1	2342	836.2	0	HET	.	.	.	A113G	.	113	113	A	504	504	A	997	A,G	801,196	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27892	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4101	847.4	0	.	n	.	0	T695C	SNP	695	695	T	1296	1296	C	990	C,G,A	987,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27892	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4101	847.4	0	.	n	.	0	G1337A	SNP	1337	1337	G	1938	1938	A	1154	A,G,C	840,311,3	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27892	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4101	847.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2572	2572	C	971	C,G,A,T	967,2,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27892	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4101	847.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2646	2646	A	952	A,T,G,C	948,1,1,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27892	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4101	847.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	3198	3198	C	979	C,T,G,A	976,1,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2296	folP	855	855	100.0	folP.l15.c4.ctg.1	1953	146.1	1	SNP	p	R229S	1	.	.	685	687	AGC	1242	1244	AGC	245;246;245	A;G,T,A;C	245;244,1,1;245	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5570	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3974	174.9	1	SNP	p	S91F	1	.	.	271	273	TTC	869	871	TTC	208;207;203	T;T,G,C;C	208;205,1,1;203	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5570	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3974	174.9	1	SNP	p	D95G	1	.	.	283	285	GGC	881	883	GGC	210;208;206	G;G;C	210;208;206	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5570	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3974	174.9	1	SNP	p	G95N	0	.	.	283	285	GGC	881	883	GGC	210;208;206	G;G;C	210;208;206	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	2090	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1918	135.8	1	SNP	p	G45D	0	.	.	133	135	GGC	799	801	GGC	229;227;227	G;G,C;C	229;226,1;227	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1068	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1584	84.1	0	.	n	.	0	A197.	DEL	197	197	A	808	808	A	239	A	239	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5106	parC	2304	2304	99.83	parC.l15.c4.ctg.1	3562	178.7	0	.	p	.	0	L479F	NONSYN	1435	1437	CTT	2017	2019	TTT	235;232;232	T;T;T	235;232;232	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5106	parC	2304	2304	99.83	parC.l15.c4.ctg.1	3562	178.7	1	SNP	p	D86N	0	.	.	256	258	GAC	838	840	GAC	232;234;231	G;A,G;C	232;233,1;231	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5106	parC	2304	2304	99.83	parC.l15.c4.ctg.1	3562	178.7	1	SNP	p	R87I	0	.	.	259	261	CGT	841	843	CGT	230;231;230	C;G;T,C	230;231;229,1	parC.WHO_V_00204c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5106	parC	2304	2304	99.83	parC.l15.c4.ctg.1	3562	178.7	1	SNP	p	R87W	0	.	.	259	261	CGT	841	843	CGT	230;231;230	C;G;T,C	230;231;229,1	parC.WHO_V_00204c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5106	parC	2304	2304	99.83	parC.l15.c4.ctg.1	3562	178.7	1	SNP	p	S87R	1	.	.	259	261	CGT	841	843	CGT	230;231;230	C;G;T,C	230;231;229,1	parC.WHO_V_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5106	parC	2304	2304	99.83	parC.l15.c4.ctg.1	3562	178.7	1	SNP	p	S88P	0	.	.	262	264	TCC	844	846	TCC	231;231;234	T;C;C	231;231;234	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4572	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3103	183.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1788	1790	GGC	259;261;261	G,A;G;C	258,1;261;261	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4376	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3153	173.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1636	1638	GCA	226;225;224	G;C,T;A	226;224,1;224	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4376	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3153	173.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1639	1641	ATC	227;227;224	A;T,G;C,T	227;226,1;223,1	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4376	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3153	173.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1651	1653	GTG	234;235;234	G;T,C;G	234;234,1;234	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4376	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3153	173.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1651	1653	GTG	234;235;234	G;T,C;G	234;234,1;234	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4376	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3153	173.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2155	2157	ACC	248;247;243	A,T,C;C;C	246,1,1;247;243	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4376	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3153	173.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2209	2211	GCG	210;211;211	G;C,T;G,T,C	210;210,1;209,1,1	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4376	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3153	173.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2209	2211	GCG	210;211;211	G;C,T;G,T,C	210;210,1;209,1,1	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4376	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3153	173.0	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2332	2334	AGC	246;245;246	A,T;G;C	245,1;245;246	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4376	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3153	173.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2341	2343	GGC	247;245;248	G;G,C;C,G	247;244,1;246,2	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4376	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3153	173.0	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2359	2361	CCG	267;264;264	C,G;C,A;G,C	265,2;263,1;263,1	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5844	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3607	202.1	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1882	1884	CCG	253;253;252	C,T,A;C,A;G,A	251,1,1;252,1;251,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2436	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2555	118.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	957	957	C	177	C,T	176,1	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	544	312	porB1a	984	100	95.0	porB1a.l15.c4.ctg.2	181	47.6	0	.	p	.	0	M18T	NONSYN	52	54	ATG	132	134	ACG	56;55;54	A;C;G	56;55;54	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	544	312	porB1a	984	100	95.0	porB1a.l15.c4.ctg.2	181	47.6	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	174	176	CAA	14;13;13	C;A;A	14;13;13	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	544	312	porB1a	984	156	92.95	porB1a.l15.c4.ctg.5	156	59.3	0	.	p	.	0	V258L	NONSYN	772	774	GTA	14	16	TTA	30;31;33	T;T;A	30;31;33	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	544	312	porB1a	984	156	92.95	porB1a.l15.c4.ctg.5	156	59.3	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	59	61	CAT	74;74;74	C;A;T	74;74;74	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	544	312	porB1a	984	156	92.95	porB1a.l15.c4.ctg.5	156	59.3	0	.	p	.	0	D274S	NONSYN	820	822	GAT	62	64	AGT	74;74;74	A;G;T	74;74;74	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	544	312	porB1a	984	156	92.95	porB1a.l15.c4.ctg.5	156	59.3	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	71	73	TAC	74;74;74	T;A;C	74;74;74	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3190	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1966	201.1	0	.	p	.	0	N38E	NONSYN	112	114	AAT	663	665	GAA	290;287;285	G;A;A	290;287;285	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3190	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1966	201.1	0	.	p	.	0	N134D	NONSYN	400	402	AAT	951	953	GAT	261;262;262	G,T;A,G;T,C	260,1;260,2;261,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3190	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1966	201.1	0	.	p	.	0	P175S	NONSYN	523	525	CCA	1074	1076	TCA	289;289;288	T,G,C;C,G;A	286,2,1;288,1;288	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3190	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1966	201.1	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1203	1205	GTC	254;253;252	G;T;C	254;253;252	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3190	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1966	201.1	0	.	p	.	0	F222S	NONSYN	664	666	TTT	1215	1217	TCT	251;249;253	T;C;T	251;249;253	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3190	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1966	201.1	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1533	1535	GCA	258;258;261	G,T;C,T,G;A	257,1;256,1,1;261	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3190	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1966	201.1	1	SNP	p	G120K	1	.	.	358	360	AAG	909	911	AAG	265;267;266	A,G;A;G	264,1;267;266	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3190	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1966	201.1	1	SNP	p	D121N	0	.	.	361	363	GAC	912	914	GAC	264;264;264	G;A;C	264;264;264	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3190	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1966	201.1	1	SNP	p	A121D	1	.	.	361	363	GAC	912	914	GAC	264;264;264	G;A;C	264;264;264	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10794	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5366	250.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1570	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1644	119.0	1	SNP	p	V57M	1	.	.	169	171	ATG	866	868	ATG	283;282;285	A,C;T;G	282,1;282;285	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
